Sign In
Buy BMY
$54.72
+0.260 (+0.477%)
At Close: Jun 03, 2026
What's in Store for These 5 Pharma Bigwigs This Earnings Season?
11:25am, Monday, 02'nd Feb 2026
As earnings season accelerates, pharma heavyweights LLY, MRK, NVO, BMY and PFE prepare to reveal their Q4 results amid a strong sector start.
Unveiling Bristol Myers (BMY) Q4 Outlook: Wall Street Estimates for Key Metrics
10:16am, Monday, 02'nd Feb 2026
Evaluate the expected performance of Bristol Myers (BMY) for the quarter ended December 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key me
Should You Buy, Hold, or Sell BMY Stock Ahead of Q4 Earnings?
09:10am, Monday, 02'nd Feb 2026
BMY heads into Q4 2025 earnings with strong Opdivo momentum, even as generic pressure continues to weigh on legacy drug sales.
Bristol Myers Squibb Company $BMY Shares Sold by United Community Bank
05:20am, Monday, 02'nd Feb 2026
United Community Bank trimmed its holdings in shares of Bristol Myers Squibb Company (NYSE: BMY) by 23.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm
Capital Management Corp VA Acquires 9,815 Shares of Bristol Myers Squibb Company $BMY
05:00am, Sunday, 01'st Feb 2026
Capital Management Corp VA increased its holdings in Bristol Myers Squibb Company (NYSE: BMY) by 9.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange
Will BMY's Oncology Collaborations Drive Its Next Growth Phase?
09:50am, Friday, 30'th Jan 2026
BMY boosts its oncology pipeline with a Janux deal on tumor-activated therapy, alongside encouraging pumitamig data and multiple cancer collaborations.
3 Top Dividend Stocks Yielding More Than 4% to Buy Hand Over Fist This Year
07:00am, Friday, 30'th Jan 2026
All three have encountered headwinds in recent years. But they have also made progress toward addressing them.
Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for
11:01am, Thursday, 29'th Jan 2026
Bristol Myers (BMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bank of New York Mellon Corp Cuts Stake in Bristol Myers Squibb Company $BMY
04:28am, Thursday, 29'th Jan 2026
Bank of New York Mellon Corp trimmed its stake in Bristol Myers Squibb Company (NYSE: BMY) by 20.1% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm
Bristol Myers Squibb (BMY) Registers a Bigger Fall Than the Market: Important Facts to Note
06:45pm, Wednesday, 28'th Jan 2026
Bristol Myers Squibb (BMY) closed the most recent trading day at $54.62, moving 1.69% from the previous trading session.
Belpointe Asset Management LLC Purchases 30,833 Shares of Bristol Myers Squibb Company $BMY
03:42am, Tuesday, 27'th Jan 2026
Belpointe Asset Management LLC boosted its position in shares of Bristol Myers Squibb Company (NYSE: BMY) by 42.6% in the third quarter, according to the company in its most recent disclosure with the
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
10:11am, Monday, 26'th Jan 2026
Bristol Myers (BMY) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Investment House LLC Sells 18,277 Shares of Bristol Myers Squibb Company $BMY
05:56am, Monday, 26'th Jan 2026
Investment House LLC lessened its holdings in shares of Bristol Myers Squibb Company (NYSE: BMY) by 57.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange
Commerzbank Aktiengesellschaft FI Lowers Position in Bristol Myers Squibb Company $BMY
05:08am, Monday, 26'th Jan 2026
Commerzbank Aktiengesellschaft FI decreased its stake in Bristol Myers Squibb Company (NYSE: BMY) by 46.6% in the third quarter, according to the company in its most recent Form 13F filing with the Se
Envestnet Portfolio Solutions Inc. Has $4.49 Million Stock Holdings in Bristol Myers Squibb Company $BMY
03:58am, Monday, 26'th Jan 2026
Envestnet Portfolio Solutions Inc. decreased its stake in shares of Bristol Myers Squibb Company (NYSE: BMY) by 9.5% during the undefined quarter, according to the company in its most recent 13F filin
